Xofigo has been approved by the US FDA for symptomatic late-stage castration-resistant prostate cancer that has reached bones but not other organs, i.e. with no known visceral metastatic disease.
UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities - the patient-reported Total Illness Burden Index for Prostate Cancer and the physician-reported Charlson Comorbidity Index - can successfully target prostate patients who would not benefit from biopsy to ... (more)
Family members will be paid to look after their disabled adult relatives after the Government set aside $23 million for carer payments in this year's Budget.
Legendary comedian and noted pot enthusiast Tommy Chong has announced that he is cancer-free and claims he has his longtime friend Mary Jane to thank for his good health.
Main Category: Prostate / Prostate Cancer Also Included In: Bones / Orthopedics ; Urology / Nephrology Article Date: 16 May 2013 - 1:00 PDT Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer .
That's the slogan of Pints for Prostate . As part of American Craft Beer Week, the Somerset Hills Hotel Tap Room will host a benefit Friday night for the organization, to help boost prostate cancer awareness through what the nonprofit calls the "universal language of beer." Pints for Prostates, a grassroots campaign started by cancer survivor Rick ... (more)
Men who are physically fit in middle age have a lower risk of developing and dying from certain cancers, new research indicates.
New overseas guidelines on who should be tested for the second-most-common cause of cancer deaths in Australian men were released recently.
When you or your loved ones are in the middle of a cancer fight, the last thing on your mind is a portrait.
Correspondence: Dr JL Wright, Department of Urology, University of Washington School of Medicine, 1959 NE Pacific, Box 356510, Seattle, WA 98195, USA.
ERG rearrangements and PTEN loss are two of the most common genetic alterations in prostate cancer.
Correspondence: Dr F Demichelis, Centre for Integrative Biology, University of Trento, Via Sommarive, 14, Povo—Trento 38123, Italy E-mail: email@example.com ; Dr H Klocker, Department of Urology, Innsbruck Medical University, Anichstr 35, Innsbruck 6020, Austria.
The U.S. Food and Drug Administration announced Wednesday that it has approved a drug to help men with advanced prostate cancer whose disease has spread to the bones.
The Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.
German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate cancer drug that could eventually generate more than 1 billion euros in annual sales.
Cambridge biopharma Tokai Pharmaceuticals Inc. has raised a $35.5M Series E round of funding led by current investors and undisclosed angel investors.